ATRC AtriCure, Inc.

NASDAQ
$51.52

AtriCure, Inc. (ATRC) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +52.9% since its last earnings release on July 23, 2026.

AtriCure Beat Consensus Estimates, Raises Earnings Guidance
Thursday, July 23, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:00 PM ET
Earnings Whisper
-
vs $0.01
Rev est $150.98M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $43.80

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AtriCure, Inc.

AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.

Sector

Healthcare

Industry

Medical Instruments/Supply